title: Aspirin for primary prevention. Treatment policy should be based on all trial evidence, not subgroup analysis.
authors.forename: L E
authors.initials: LE
authors.lastname: Ramsay
authors.forename: P S
authors.initials: PS
authors.lastname: Sanmuganathan
authors.forename: E J
authors.initials: EJ
authors.lastname: Wallis
authors.forename: P R
authors.initials: PR
authors.lastname: Jackson
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000150:complications; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011322:Primary Prevention; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin